Digital Health App for Autism
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test a mobile app called KeepCalm, designed to help manage stress and challenging behaviors in children with autism. The app monitors heart rate to detect stress and suggests personalized strategies for teachers to use in the classroom. It also enables teachers to track effective methods and share this information with parents. This app suits preschool or elementary school children with autism who exhibit challenging behaviors such as aggression or loud noises, and it requires teachers or aides who can use an iPhone. As an unphased trial, the study provides a unique opportunity to explore innovative solutions for managing autism-related challenges.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that this m-health app is safe for children with autism?
Research has shown that the KeepCalm app is safe for children with autism. The app manages stress and challenging behaviors by monitoring heart rate and offering helpful tips. As a digital tool, it involves no physical contact.
Studies of similar apps indicate that digital health tools like KeepCalm are usually well-received, with users reporting few, if any, side effects. The app avoids medication, thus eliminating risks such as drug side effects or allergies.
Overall, current research suggests that the KeepCalm app is safe. It provides a gentle way to help children with autism manage their emotions and behaviors.12345Why are researchers excited about this trial?
Researchers are excited about the KeepCalm app because it offers a new way to manage stress and prevent challenging behaviors in children with autism. Unlike traditional behavioral therapies that require consistent in-person sessions, the app provides real-time physiological stress tracking using heart rate monitoring. This allows the app to anticipate when challenging behaviors might occur and suggest strategies to prevent them, making it a proactive tool. Additionally, it helps track and communicate behavioral trends and triggers, providing valuable insights to parents and educators.
What evidence suggests that the KeepCalm app is effective for managing challenging behaviors in children with autism?
In this trial, participants will either use the KeepCalm app or join a waitlist control group. Studies have shown that the KeepCalm app can help children with autism manage their emotions. It uses wearable technology to monitor heart rate and predict stress levels. The app offers personalized tips to help control emotions and reduce difficult behaviors. Early research indicates that it also assists teachers by suggesting specific strategies and tracking which ones are most effective for each child. Based on proven methods, the app is a promising tool for managing stress in children with autism. Overall, the KeepCalm app shows potential in providing a more customized way to handle challenging behaviors in these children.25678
Are You a Good Fit for This Trial?
This trial is for preschool or elementary school children with autism who exhibit challenging behaviors such as aggression, non-compliance, and self-injury. A parent and teacher or aide must participate, and they need access to an iPhone to use the KeepCalm app.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Development and Pilot Testing
Development and pilot testing of the KeepCalm app, including interviews and structured observations with teachers, parents, and school administrators.
Randomized Waitlist Field Trial
Testing the app for usability, acceptability, feasibility, and preliminary effectiveness with 30 educational teams.
Follow-up
Participants are monitored for safety and effectiveness after the trial period.
What Are the Treatments Tested in This Trial?
Interventions
- KeepCalm app
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
Alevio LLC
Collaborator
Alevio Inc.
Collaborator